Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://aoifepcbj361293.blogofoto.com/70186773/retaglutide-a-promising-glp-1-receptor-agonist